Especially, the BRA should be done contemplating the therapeutic context of your assessed drug. The reflection paper also emphasizes the uncertainties and variability of those estimations as well as their impact on the decision. Next, it has an acknowledgment of the need to guidance investigation in the event of quantitative or semiquantitative BRA